[
  {
    "ts": null,
    "headline": "Safe Biopharma: Revvity's Recurring Revenues And Diagnostics",
    "summary": "Revvity's recurring revenue base from consumables, services, and software ensures predictable income. Read why RVTY stock is a buy in the biopharma sector.",
    "url": "https://finnhub.io/api/news?id=14a1a6ed43d15035e7931a2c3106ff2f2bf3cea303f76dec99eb904129525725",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734308871,
      "headline": "Safe Biopharma: Revvity's Recurring Revenues And Diagnostics",
      "id": 132007563,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2143914595/image_2143914595.jpg?io=getty-c-w1536",
      "related": "RVTY",
      "source": "SeekingAlpha",
      "summary": "Revvity's recurring revenue base from consumables, services, and software ensures predictable income. Read why RVTY stock is a buy in the biopharma sector.",
      "url": "https://finnhub.io/api/news?id=14a1a6ed43d15035e7931a2c3106ff2f2bf3cea303f76dec99eb904129525725"
    }
  }
]